Abstract
We examined whether plasma high-density lipoprotein-cholesterol (HDL-C) levels and glucose metabolism parameters are independent or additive predictors of left ventricular hypertrophy (LVH) in patients with untreated essential hypertension. The study group consisted of 41 Japanese patients with untreated essential hypertension and LVH (left ventricular mass index [LVMI] >125 g/m2; age 58±6 years, mean±SD), and the control group consisted of 39 age-matched patients with untreated essential hypertension without LVH (LVMI ≤125 g/m2; age 58±7 years). The following metabolic parameters were higher in the group with LVH: fasting plasma glucose (FPG) (p<0.01), fasting insulin concentration (F-IRI) (p<0.0001), and homeostasis model assessment (HOMA)-index (p<0.0001). Among the laboratory parameters investigated, plasma HDL-C levels were lower (p<0.0001), and triglyceride and uric acid levels were higher in the group with LVH (p<0.05 for both). The nighttime systolic and diastolic ambulatory blood pressure (ABP) (p<0.0001, p<0.01, respectively) and nighttime heart rate (p<0.01) were higher in patients with LVH. Multivariate logistic analysis identified HDL-C (odds ratio [OR]=0.92, 95% confidence interval [CI]=0.87–0.98, p<0.05), HOMA-index (OR=3.83, 95% CI=1.28–11.5, p<0.05) and nighttime systolic ambulatory blood pressure (ABP) (OR=1.06, 95% CI=1.00–1.13, p<0.05) as independent significant risk factors for LVH. Our findings suggest that HDL-C, HOMA-index and nighttime systolic ABP are independent predictors for the presence of LVH in Japanese patients with essential hypertension.
Similar content being viewed by others
Article PDF
References
Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH : Relation of left ventricular mass and geometry to morbidity in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP : Prognostic implications of echocardiographically-determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.
Denker PS, Pollock VE : Fasting serum insulin levels in essential hypertension: a meta-analysis. Arch Intern Med 1992; 152: 1649–1651.
Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H : Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J Hypertens 1999; 17: 1153–1160.
Cuspidi C, Macca G, Sampieri L, et al: Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens 2001; 19: 1539–1545.
Verdecchia P, Porcellati C, Schillaci G, et al: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801.
Eto M, Toba K, Akishita M, et al: Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension. Hypertens Res 2005; 28: 1–7.
Anan F, Takahashi N, Ooie T, Yufu K, Saikawa T, Yoshimatsu H : Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003; 26: 669–676.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP : Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989; 110: 101–107.
Horio T, Miyazato J, Kamide K, Takiuchi S, Kawano Y : Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension. Am J Hypertens 2003; 16: 938–944.
Schillaci G, Vaudo G, Reboldi G, et al: High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension. J Hypertens 2001; 19: 2265–2270.
Chen W, Srinivasan SR, Elkasabany A, Berenson GS : Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescent, and young adults: the Bogalusa Heart Study. Am J Epidemiol 1999; 150: 667–674.
Steinberger J, Moorehead C, Katch V, Rocchini AP : Relationships between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995; 126: 690–695.
Pickering TG, Ad Hoc Panel : Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996; 9: 1–11.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA 2001; 285: 2486–2497.
Tochikubo O, Ikeda A, Miyajima E, Ishii M : Effect of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27: 1318–1324.
Kohara K, Nishida W, Maguchi M, Hiwada K : Autonomic nervous function in non-dipper essential hypertensive subjects. Evaluation by power spectral analysis of heart rate variability. Hypertension 1995; 26: 808–814.
Verdecchia P, Schillaci G, Guerrieri M, et al: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528–536.
Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.
Verdecchia P, Schillaci G, Porcellati C, Cuccurullo O, Cosco C, Perticone F : Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35: 580–586.
Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
Taniguchi A, Fukushima M, Sakai M, et al: Remnant-like particle cholesterol, triglyceride, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000; 23: 1766–1769.
Ferrannini E, Haffner SM, Mitchell BD, Stern MP : Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416–422.
Grundy SM : Hypertriglycemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F–29F.
Scherrer U, Sartori C : Insulin as vascular and sympathoexcitatory hormone: implication for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96: 4104–4113.
Rocchini AP, Katch V, Kveselis D, et al: Insulin and renal sodium retention in obese adolescents. Hypertension 1989; 14: 367–374.
Hsueh WA, Law RE : Insulin signaling in the arterial wall. Am J Cardiol 1999; 84: 21J–24J.
Ito H, Hiroe M, Hirata Y, et al: Insulin-like growth factor-1 induces cardiac hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation 1993; 87: 1715–1721.
Facchini FS, Stoohs RA, Reaven GM : Enhanced sympathetic nervous system activity. Am J Hypertens 1995; 9: 1013–1017.
Takahashi N, Nakagawa M, Saikawa T, et al: Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients. J Am Coll Cardiol 2001; 38: 232–237.
Douglas P, Tallant B : Hypertrophy, fibrosis and diastolic dysfunction in early canine experiment hypertension. J Am Coll Cardiol 1991; 17: 117–119.
Hoshide S, Kario K, Hoshide Y, et al: Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens 2003; 16: 434–438.
Fagard R, Staessen J, Thijis L, Amery A : Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring: a metaanalysis of comparative studies. Am J Hypertens 1995; 8: 533–540.
Morgan HE, Baker KM : Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 1991; 83: 13–25.
Ono A, Fujita T : Predictors of controlled ambulatory blood pressure in treated hypertensive patients with uncontrolled office blood pressure. Hypertens Res 2004; 27: 805–811.
Toikka JO, Ahotupa M, Viikari JS, et al: Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo. LDL-oxidant in healthy young men. Atherosclerosis 1999; 147: 133–138.
Perticone F, Maio R, Ceravolo R, et al: Relationship between left ventricular mass and endothelium-dependent vasodilatation in never-treated hypertensive patients. Circulation 1999; 99: 1991–1996.
Shigematsu Y, Norimatsu S, Ohtsuka T, Okayama H, Higaki J : Sex-related differences in the relations of insulin resistance and obesity to left ventricular hypertrophy in Japanese hypertensive patients. Hypertens Res 2006; 29: 499–504.
Verdecchia P, Schillaci G, Guerrieri M, et al: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528–536.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Anan, F., Yonemochi, H., Masaki, T. et al. High-Density Lipoprotein Cholesterol and Insulin Resistance Are Independent and Additive Markers of Left Ventricular Hypertrophy in Essential Hypertension. Hypertens Res 30, 125–131 (2007). https://doi.org/10.1291/hypres.30.125
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.30.125
Keywords
This article is cited by
-
The relationship between the weight-adjusted-waist index and left ventricular hypertrophy in Chinese hypertension adults
Hypertension Research (2023)
-
Triglycerides are related to left ventricular mass in hypertensive patients independently of other cardiometabolic risk factors: the effect of gender
Scientific Reports (2020)
-
The impact of nontraditional lipid profiles on left ventricular geometric abnormalities in general Chinese population
BMC Cardiovascular Disorders (2018)